As a Business Development & Investment Manager, Elliott is responsible for licensing university technologies to industry partners and forming university spin-out companies. He specifically focuses on technologies and spin-out companies in the life science sector.
Elliott was previously a Business Manager at the medical research charity LifeArc, where he supported commercialisation of intellectual property owned by the Medical Research Council. Prior to this, he received training in technology transfer as part of LifeArc’s Technology Transfer Programme. During this one-year programme, Elliott was seconded to some of London’s leading technology transfer offices – the Imperial College Enterprise Division, UCL Business, and Queen Mary Innovation. Elliott has a research background in infectious diseases and immunology, holding a PhD from Imperial College London.
AbBind: A novel virus-like particule platform
AbBind is an antibody compatible, plug-and-play virus-like particle platform with applications in vaccinology and tissue-specific gene therapy.
KOKU Health Ltd - helping older adults improve strength, balance and optimise healthy ageing
KOKU Health Ltd. is a spinout from The University of Manchester, developing a digital platform for falls prevention and health literacy in older adults